Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
BWEL: Breast Cancer Weight Loss Trial
Sponsor: NCI Alliance
Enrolling: Female Patients Only
IRB Number: AAAR1073
U.S. Govt. ID: NCT02750826
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence). Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring, as compared to women who were thinner when their cancer was diagnosed. This study aims to test whether overweight or obese women who take part in a weight loss program after being diagnosed with breast cancer have a lower rate of cancer recurrence as compared to women who do not take part in the weight loss program. This study will help to show whether weight loss programs should be a part of breast cancer treatment.
This study is closed
Dawn Hershman, MD
Do You Qualify?
Are you a woman who is 18 years of age or older? Yes No
Have you been diagnosed with invasive breast cancer in the past 12 months? Yes No
Do you have a BMI of greater than or equal to 27 kg/m2 (overweight)? Yes No
Are you able to walk at least 2 blocks? Yes No
Are you participating in any other weight loss, physical activity, or dietary intervention study? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator